Table 4.
Details of clinical outcomes.
| Non-PD group | PD group | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | Post HAL | 1 M follow-up | 3 M follow-up | Baseline | Post HAL | 1 M follow-up | 3 M follow-up | |
| 10 MWT (s) | 23.3 [13.5, 46.3] |
15.9 [10.8, 30.2] (0.012) |
16.3 [10.2, 25.3] (0.012) |
18.5 [10.3, 34.6] (0.012) |
15.3 [10.6, 26.7] |
9.6 [8.5, 13.3] (<0.001) |
12.0 [9.4, 13.8] (0.001) |
10.4 [10.1, 10.9] (0.006) |
| Step length (m) | 0.38 [0.19, 0.43] |
0.43 [0.26, 0.49] (0.012) |
0.46 [0.32, 0.53] (0.012) |
0.41 [0.24, 0.49] (0.012) |
0.37 [0.28, 0.47] |
0.51 [0.42, 0.60] (<0.001) |
0.42 [0.40, 0.48] (0.001) |
0.52 [0.47, 0.57] (0.003) |
| TUG (s) | 30.1 [17.5, 47.0] |
18.3 [11.3, 28.8] (0.012) |
20.5 [11.0, 31.6] (0.012) |
27.1 [13.1, 42.6] (0.093) |
17.7 [12.9, 22.7] |
14.0 [10.1, 20.2] (<0.001) |
14.6 [11.5, 17.8] (0.002) |
11.7 [11.5, 18.3] (0.136) |
| CST-30 (times) | 4.5 [0.0, 7.3] |
6.0 [3.8, 8.3] (0.017) |
6.0 [3.8, 9.5] (0.011) |
7.5 [3.8, 8.8] (0.024) |
4.0 [2.3, 4.3] |
6.5 [5.8, 8.3] (0.001) |
7.0 [7.0, 9.0] (0.001) |
9.0 [6.8, 11.8] (0.006) |
| VAS at rest | 35.5 [23.3, 48.5] |
8.0 [3.8, 16.3] (0.036) |
10.5 [1.5, 14.0] (0.012) |
23.0 [17.8, 28.5] (0.233) |
||||
| VAS in motion | 49.0 [19.5, 55.3] |
9.5 [4.5, 18.5] (0.017) |
11.0 [5.8, 17.8] (0.028) |
24.0 [10.8, 31.8] (0.176) |
||||
10 MWT, 10 m walking test; CST-30, 30 s chair stand test; HAL, hybrid assistive limb; PD, Parkinson's disease; TUG, timed up-and-go test; VAS, visual analog scale.
Measured values are presented as median [interquartile range] and (p-values compared to baseline).